Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-16
2006-05-16
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210010, C514S426000, C544S107000, C548S557000, C564S139000
Reexamination Certificate
active
07045521
ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
REFERENCES:
patent: 4851423 (1989-07-01), Girijavallabhan et al.
patent: 5272167 (1993-12-01), Girijavallabhan et al.
patent: 5710171 (1998-01-01), Dinsmore et al.
patent: 5770620 (1998-06-01), Mjalli et al.
patent: 5968965 (1999-10-01), Dinsmore et al.
patent: 5981491 (1999-11-01), Baxter et al.
patent: 6011052 (2000-01-01), Padia et al.
patent: 6028087 (2000-02-01), Bondinell et al.
patent: 6030946 (2000-02-01), Klaus et al.
patent: 6048861 (2000-04-01), Askew et al.
patent: 6084065 (2000-07-01), Cammaggi et al.
patent: 6100423 (2000-08-01), Collins et al.
patent: 6162790 (2000-12-01), Bemis et al.
patent: 6706712 (2004-03-01), Cherney
patent: 2003/0060459 (2003-03-01), Cherney et al.
patent: 2003/0216434 (2003-11-01), Cherney
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235835 (2004-11-01), Carter
patent: 2004/0235836 (2004-11-01), Cherney
patent: 0264795 (1987-10-01), None
patent: 0560407 (1987-12-01), None
patent: 0731107 (1996-02-01), None
patent: 377869 (1991-03-01), None
patent: 93/15047 (1993-08-01), None
patent: 94/03479 (1994-02-01), None
patent: 94/20062 (1994-09-01), None
patent: 96/22966 (1996-08-01), None
patent: 97/00894 (1997-01-01), None
patent: 98/06703 (1998-02-01), None
patent: 99/07351 (1999-02-01), None
patent: 99/07678 (1999-02-01), None
patent: 99/17790 (1999-04-01), None
patent: 99/25686 (1999-05-01), None
patent: 99/40913 (1999-08-01), None
patent: 99/40914 (1999-08-01), None
patent: 97/44329 (1999-11-01), None
patent: 00/42071 (2000-07-01), None
patent: 00/46196 (2000-08-01), None
patent: 00/69815 (2000-11-01), None
patent: 00/69820 (2000-11-01), None
patent: 00/76512 (2000-12-01), None
patent: WO 0250019 (2002-06-01), None
patent: WO 02060859 (2002-08-01), None
patent: WO 03075853 (2003-09-01), None
patent: WO 2004/071460 (2004-08-01), None
patent: WO 2004071449 (2004-08-01), None
patent: WO 2004098512 (2004-11-01), None
patent: WO 2004098516 (2004-11-01), None
Cutrufo et al., Eu. J. Pharm. (1999), vol. 374, No. 2, pp. 277-283.
U.S. Appl. No. 10/922,406, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,619, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/922,726, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,538, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/776,828, filed Feb. 11, 2004, Cherney et al.
Baba et al., A Small-Molecule, Nonpeptide CCR5 Antagonist With Hihgly Potent and Selective Anti-HIV-1 Activity, Proc. Natl. Acad. Sci., May 1999, vol. 96, pp. 5698-5703.
Forbes, et al., CCR2B Receptor Antagonists: Conversion of a Weak HTS it to a Potent Lead Compound, Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, pp. 1803-1806.
Mirzadegan, et al. Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists, The Journal of Biological Chemistry, 2000, vol. 275 No. 33, pp. 25562-25571.
Bristol-Myers Squibb Pharma Company
Solola Taofiq
Van Atten Mary
LandOfFree
Cyclic derivatives as modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic derivatives as modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic derivatives as modulators of chemokine receptor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3638030